HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maurizio Pellecchia Selected Research
Maurizio Pellecchia Research Topics
Disease
69
Neoplasms (Cancer)
11/2022 - 12/2003
18
Melanoma (Melanoma, Malignant)
11/2021 - 04/2009
12
Prostatic Neoplasms (Prostate Cancer)
10/2020 - 02/2006
8
Neoplasm Metastasis (Metastasis)
10/2020 - 12/2012
8
Leukemia
07/2018 - 09/2003
6
Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 01/2015
5
Infections
11/2017 - 01/2006
4
Human Influenza (Influenza)
10/2015 - 07/2007
4
Carcinogenesis
07/2012 - 09/2003
4
Anthrax
09/2010 - 07/2005
3
Breast Neoplasms (Breast Cancer)
06/2021 - 05/2010
3
Adenocarcinoma
01/2015 - 09/2010
3
Lymphoma (Lymphomas)
01/2011 - 07/2005
3
B-Cell Lymphoma (Lymphoma, B Cell)
11/2010 - 07/2009
2
Inflammation (Inflammations)
01/2016 - 01/2006
2
Glioma (Gliomas)
01/2015 - 01/2014
2
Plague (Bubonic Plague)
01/2013 - 03/2005
2
Carcinoma (Carcinomatosis)
06/2010 - 11/2009
1
Pneumonia (Pneumonitis)
11/2020
1
Chronic Obstructive Pulmonary Disease (COPD)
11/2020
1
Emphysema
11/2020
1
Confusion (Bewilderment)
01/2020
1
Multiple Myeloma
07/2018
1
Circulating Neoplastic Cells
01/2018
1
Shock
11/2017
1
Sepsis (Septicemia)
11/2017
1
Septic Shock (Toxic Shock Syndrome)
11/2017
1
Brain Neoplasms (Brain Tumor)
10/2017
1
Glioblastoma (Glioblastoma Multiforme)
10/2017
1
Yersinia Infections
04/2016
1
Atherosclerotic Plaque (Atheroma)
04/2016
1
Drug-Related Side Effects and Adverse Reactions
03/2016
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2015
Drug/Important Bio-Agent (IBA)
32
Proteins (Proteins, Gene)
FDA Link
11/2021 - 09/2003
9
Ligands
IBA
11/2022 - 02/2006
9
EphA2 Receptor
IBA
10/2020 - 12/2008
9
Peptides (Polypeptides)
IBA
01/2018 - 07/2007
7
1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamide
IBA
06/2015 - 05/2010
6
Paclitaxel (Taxol)
FDA Link
Generic
11/2022 - 03/2012
6
Syntenins
IBA
10/2017 - 12/2012
6
Cytokines
IBA
03/2016 - 06/2010
6
apogossypol
IBA
05/2012 - 03/2008
4
Antineoplastic Agents (Antineoplastics)
IBA
01/2017 - 05/2010
4
Interleukins
IBA
01/2015 - 06/2010
4
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
11/2014 - 03/2005
3
3- (3- (1H- benzo(d)imidazol- 2- yl)acryloyl)- 6- chloro- 4- phenylquinolin- 2(1H)- one
IBA
01/2013 - 04/2009
3
Polyphenols
IBA
01/2004 - 09/2003
2
Protein Isoforms (Isoforms)
IBA
01/2016 - 12/2010
2
ABT-737
IBA
07/2015 - 05/2011
2
Caspases
IBA
06/2015 - 11/2005
2
Phosphotransferases (Kinase)
IBA
04/2015 - 10/2011
2
Hemagglutinins (Hemagglutinin)
IBA
02/2015 - 07/2007
2
Matrix Metalloproteinases (MMPs)
IBA
01/2015 - 05/2012
2
Collagen
IBA
01/2015 - 05/2012
2
Lipids
IBA
11/2014 - 12/2008
2
AD 5
IBA
01/2014 - 05/2012
2
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
08/2013 - 12/2009
2
Gossypol
IBA
11/2012 - 03/2008
2
Proline (L-Proline)
FDA Link
01/2012 - 12/2007
2
Glutamic Acid (Glutamate)
FDA Link
10/2011 - 11/2005
2
Tyrosine (L-Tyrosine)
FDA Link
10/2011 - 03/2005
2
Interleukin-10 (Interleukin 10)
IBA
05/2011 - 06/2010
2
Ubiquitin
IBA
09/2010 - 12/2009
2
Ligases (Synthetase)
IBA
09/2010 - 12/2009
2
Metalloproteases (Metalloproteinases)
IBA
09/2010 - 07/2005
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2009 - 02/2006
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2022
1
Lysine (L-Lysine)
FDA Link
11/2021
1
Indicators and Reagents (Reagents)
IBA
06/2021
1
Streptavidin
IBA
06/2021
1
Interleukin-4 (Interleukin 4)
IBA
11/2020
1
Pancreatic Elastase (Elastase)
IBA
11/2020
1
enzalutamide
IBA
10/2020
1
Serine Proteases (Serine Protease)
IBA
01/2020
1
LCL161
IBA
07/2018
1
Lipopolysaccharides
IBA
11/2017
1
Resistin
IBA
11/2017
1
Syndecans
IBA
10/2017
1
Carrier Proteins (Binding Protein)
IBA
10/2017
1
Gemcitabine
FDA Link
03/2016
1
Nucleosides
IBA
03/2016
1
Hormones (Hormone)
IBA
03/2016
1
Adenosine Deaminase
IBA
01/2016
1
Inosine
FDA Link
01/2016
1
RNA I
IBA
01/2016
1
Antimicrobial Peptides
IBA
01/2016
1
Adenosine (Adenocard)
FDA Link
Generic
01/2016
1
SBI-0640756
IBA
12/2015
1
Peptide Initiation Factors (Initiation Factor)
IBA
12/2015
1
Eukaryotic Initiation Factor-4F (EIF4F)
IBA
12/2015
1
RNA (Ribonucleic Acid)
IBA
10/2015
1
navitoclax
IBA
07/2015
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
06/2015
1
Celecoxib (Celebrex)
FDA Link
06/2015
Therapy/Procedure
35
Therapeutics
11/2022 - 03/2004
11
Drug Therapy (Chemotherapy)
11/2022 - 01/2004
2
Chemoprevention
01/2004 - 12/2003
1
Immunomodulation
11/2017
1
Radiotherapy
10/2017
1
Immunotherapy
03/2016